Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anthony J. Lembo, M.D.

Co-Author

This page shows the publications co-authored by Anthony Lembo and Sarah Ballou.
Connection Strength

10.062
  1. Editorial: symptom improvement does not equal satisfaction with treatment for constipation. Aliment Pharmacol Ther. 2020 05; 51(9):909-910.
    View in: PubMed
    Score: 0.872
  2. Brief Behavioral Therapy for Insomnia in Patients with Irritable Bowel Syndrome: A Pilot Study. Dig Dis Sci. 2020 11; 65(11):3260-3270.
    View in: PubMed
    Score: 0.863
  3. Obesity is associated with significantly increased risk for diarrhoea after controlling for demographic, dietary and medical factors: a cross-sectional analysis of the 2009-2010 National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2019 11; 50(9):1019-1024.
    View in: PubMed
    Score: 0.835
  4. Sleep Disturbances Are Commonly Reported Among Patients Presenting to a Gastroenterology Clinic. Dig Dis Sci. 2018 11; 63(11):2983-2991.
    View in: PubMed
    Score: 0.773
  5. Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation. Clin Gastroenterol Hepatol. 2018 11; 16(11):1738-1744.e1.
    View in: PubMed
    Score: 0.756
  6. Are they side effects? Extra-intestinal symptoms reported during clinical trials of IBS may be more severe at baseline. Clin Gastroenterol Hepatol. 2022 Mar 23.
    View in: PubMed
    Score: 0.248
  7. Patients' experiences treated with open-label placebo versus double-blind placebo: a mixed methods qualitative study. BMC Psychol. 2022 Feb 04; 10(1):20.
    View in: PubMed
    Score: 0.246
  8. Belching: Pathogenesis, Clinical Characteristics, and Treatment Strategies. J Clin Gastroenterol. 2022 01 01; 56(1):36-40.
    View in: PubMed
    Score: 0.245
  9. Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders. Neurogastroenterol Motil. 2022 Apr; 34(4):e14253.
    View in: PubMed
    Score: 0.240
  10. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial. Pain. 2021 09 01; 162(9):2428-2435.
    View in: PubMed
    Score: 0.239
  11. Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders. Am J Gastroenterol. 2021 08 01; 116(8):1720-1726.
    View in: PubMed
    Score: 0.238
  12. Improving Medication Tolerance: A Pilot Study in Disorders of Gut-brain Interaction Treated With Tricyclic Antidepressants. J Clin Gastroenterol. 2021 Jun 07.
    View in: PubMed
    Score: 0.235
  13. Fecal Urgency: Clinical and Manometric Characteristics in Patients With and Without Diarrhea. Dig Dis Sci. 2020 12; 65(12):3679-3687.
    View in: PubMed
    Score: 0.219
  14. Symptom Severity, Mood, and Healthcare Use Are Associated With Satisfaction in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2020 12; 18(13):2945-2951.e1.
    View in: PubMed
    Score: 0.215
  15. Placebo Response in Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2019 12; 114(12):1838-1846.
    View in: PubMed
    Score: 0.212
  16. Randomized Clinical Trial: Crofelemer Treatment in Women With Diarrhea-Predominant Irritable Bowel Syndrome. Clin Transl Gastroenterol. 2019 12; 10(12):e00110.
    View in: PubMed
    Score: 0.212
  17. Use of Treatments for Irritable Bowel Syndrome and Patient Satisfaction Based on the IBS in America Survey. Gastroenterology. 2020 02; 158(3):786-788.e1.
    View in: PubMed
    Score: 0.211
  18. Information- and Health-care Seeking Behaviors in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2020 11; 18(12):2840-2842.
    View in: PubMed
    Score: 0.209
  19. Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea. Clin Gastroenterol Hepatol. 2020 02; 18(2):399-405.e1.
    View in: PubMed
    Score: 0.208
  20. Effects of Irritable Bowel Syndrome on Daily Activities Vary Among Subtypes Based on Results From the IBS in America Survey. Clin Gastroenterol Hepatol. 2019 11; 17(12):2471-2478.e3.
    View in: PubMed
    Score: 0.207
  21. Chronic Diarrhea and Constipation Are More Common in Depressed Individuals. Clin Gastroenterol Hepatol. 2019 12; 17(13):2696-2703.
    View in: PubMed
    Score: 0.202
  22. Fecal urgency is common in constipated patients and is associated with anxiety. Neurogastroenterol Motil. 2019 04; 31(4):e13545.
    View in: PubMed
    Score: 0.200
  23. Emergency Department Burden of Gastroparesis in the United States, 2006 to 2013. J Clin Gastroenterol. 2019 02; 53(2):109-113.
    View in: PubMed
    Score: 0.200
  24. Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013. J Clin Gastroenterol. 2018 10; 52(9):778-783.
    View in: PubMed
    Score: 0.195
  25. Clinical and manometric characteristics of women with paradoxical puborectalis syndrome. United European Gastroenterol J. 2018 Dec; 6(10):1578-1585.
    View in: PubMed
    Score: 0.194
  26. Demographic and Dietary Associations of Chronic Diarrhea in a Representative Sample of Adults in the United States. Am J Gastroenterol. 2018 04; 113(4):593-600.
    View in: PubMed
    Score: 0.188
  27. Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2018 09; 16(9):1450-1458.e2.
    View in: PubMed
    Score: 0.187
  28. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018 10; 16(10):1569-1584.e2.
    View in: PubMed
    Score: 0.186
  29. Characterizing Normal Bowel Frequency and Consistency in a Representative Sample of Adults in the United States (NHANES). Am J Gastroenterol. 2018 01; 113(1):115-123.
    View in: PubMed
    Score: 0.180
  30. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Trials. 2017 05 25; 18(1):234.
    View in: PubMed
    Score: 0.178
  31. Irritable bowel syndrome and diet. Gastroenterol Rep (Oxf). 2017 02; 5(1):11-19.
    View in: PubMed
    Score: 0.174
  32. Diminished androgen levels are linked to irritable bowel syndrome and cause bowel dysfunction in mice. J Clin Invest. 2022 01 18; 132(2).
    View in: PubMed
    Score: 0.061
  33. Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial. Am J Gastroenterol. 2021 11 01; 116(11):2279-2285.
    View in: PubMed
    Score: 0.060
  34. Symptom severity and clinical characteristics of patients with bloating. Neurogastroenterol Motil. 2022 Mar; 34(3):e14229.
    View in: PubMed
    Score: 0.060
  35. Clinical and Psychological Factors Predict Outcome in Patients With Functional Dyspepsia: A Prospective Study. Clin Gastroenterol Hepatol. 2021 Jul 31.
    View in: PubMed
    Score: 0.059
  36. Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation. J Clin Gastroenterol. 2020 04; 54(4):365-369.
    View in: PubMed
    Score: 0.054
  37. Prevalence of Functional GI Diseases and Pelvic Floor Symptoms in Marfan Syndrome and Ehlers-Danlos Syndrome: A National Cohort Study. J Clin Gastroenterol. 2019 10; 53(9):653-659.
    View in: PubMed
    Score: 0.052
  38. Pelvic Floor Symptom Related Distress in Chronic Constipation Correlates With a Diagnosis of Irritable Bowel Syndrome With Constipation and Constipation Severity but Not Pelvic Floor Dyssynergia. J Neurogastroenterol Motil. 2019 Jan 31; 25(1):129-136.
    View in: PubMed
    Score: 0.050
  39. Prevalence of Chronic Constipation and Chronic Diarrhea in Diabetic Individuals in the United States. Am J Gastroenterol. 2019 01; 114(1):135-142.
    View in: PubMed
    Score: 0.050
  40. Significant Morbidity and Mortality Associated with Fecal Impaction in Patients Who Present to the Emergency Department. Dig Dis Sci. 2019 05; 64(5):1320-1327.
    View in: PubMed
    Score: 0.049
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.